Publications

FutureMS cohort profile: a Scottish multicentre inception cohort study of relapsing-remitting multiple sclerosis.

Kearns PKA, Martin SJ, Chang J, Meijboom R, York EN, Chen Y, Weaver C, Stenson A, Hafezi K, Thomson S, Freyer E, Murphy L, Harroud A, Foley P, Hunt D, McLeod M, O'Riordan J, Carod-Artal FJ, MacDougall NJJ, Baranzini SE, Waldman AD, Connick P, Chandran S

BMJ open, 2022

Progress Toward a Universal Biomedical Data Translator.

Fecho K, Thessen AT, Baranzini SE, Bizon C, Hadlock JJ, Huang S, Roper RT, Southall N, Ta C, Watkins PB, Williams MD, Xu H, Byrd W, Dancík V, Duby MP, Dumontier M, Glusman G, Harris NL, Hinderer EW, Hyde G, Johs A, Su A, Qin G, Zhu Q, Biomedical Data Translator Consortium

Clinical and translational science, 2022

Polygenic risk score association with multiple sclerosis susceptibility and phenotype in Europeans.

Shams H, Shao X, Santaniello A, Kirkish G, Harroud A, Ma Q, Isobe N, University of California San Francisco MS-EPIC Team, Schaefer C, McCauley JL, Cree BAC, Didonna A, Baranzini SE, Patsopoulos NA, Hauser SL, Barcellos LF, Henry RG, Oksenberg JR

Brain : a journal of neurology, 2022

Embedding electronic health records onto a knowledge network recognizes prodromal features of multiple sclerosis and predicts diagnosis.

Nelson CA, Bove R, Butte AJ, Baranzini SE

Journal of the American Medical Informatics Association : JAMIA, 2021

Distinctive waves of innate immune response in the retina in experimental autoimmune encephalomyelitis.

Cruz-Herranz A, Oertel FC, Kim K, Cantó E, Timmons G, Sin JH, Devereux M, Baker N, Michel B, Schubert RD, Rani L, Cordano C, Baranzini SE, Green AJ

JCI insight, 2021

Childhood obesity and multiple sclerosis: A Mendelian randomization study.

Harroud A, Mitchell RE, Richardson TG, Morris JA, Forgetta V, Davey Smith G, Baranzini SE, Richards JB

Multiple sclerosis (Houndmills, Basingstoke, England), 2021

Knowledge Network Embedding of Transcriptomic Data from Spaceflown Mice Uncovers Signs and Symptoms Associated with Terrestrial Diseases.

Nelson CA, Acuna AU, Paul AM, Scott RT, Butte AJ, Cekanaviciute E, Baranzini SE, Costes SV

Life (Basel, Switzerland), 2021

Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis.

Pröbstel AK, Zhou X, Baumann R, Wischnewski S, Kutza M, Rojas OL, Sellrie K, Bischof A, Kim K, Ramesh A, Dandekar R, Greenfield AL, Schubert RD, Bisanz JE, Vistnes S, Khaleghi K, Landefeld J, Kirkish G, Liesche-Starnecker F, Ramaglia V, Singh S, Tran EB, Barba P, Zorn K, Oechtering J, Forsberg K, Shiow LR, Henry RG, Graves J, Cree BAC, Hauser SL, Kuhle J, Gelfand JM, Andersen PM, Schlegel J, Turnbaugh PJ, Seeberger PH, Gommerman JL, Wilson MR, Schirmer L, Baranzini SE

Science immunology, 2020

Mendelian randomization study shows no causal effects of serum urate levels on the risk of MS.

Harroud A, Richards JB, Baranzini SE

Neurology(R) neuroimmunology & neuroinflammation, 2020

Levels of brain-derived neurotrophic factor in patients with multiple sclerosis.

Naegelin Y, Saeuberli K, Schaedelin S, Dingsdale H, Magon S, Baranzini S, Amann M, Parmar K, Tsagkas C, Calabrese P, Penner IK, Kappos L, Barde YA

Annals of clinical and translational neurology, 2020

Pages